Skip to main content
Premium Trial:

Request an Annual Quote

Australian Genome Research Facility to Use NimbleGen s Microarray Technology

NEW YORK, Oct. 18 (GenomeWeb News) - The Australian Genome Research Facility will use microarray technology from NimbleGen Systems, the Madison, Wis.-based company said last week.


Joining NimbleGen's "Custom Microarray Core Facility" program, AGRF will offer its researchers customized arrays produced with NimbleGen's maskless array synthesizer technology.


AGRF, which has operations in Brisbane, Melbourne, and Adelaide, already has platforms from Affymetrix, Sequenom, and Applied Biosystems in place.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more